You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
- Three innovators awarded $200,000 in total grants and resources for their work to "Change Cancer Care" beyond medicine - NORTHBROOK, Ill., March 24, 2021 /PRNewswire/ -- Astellas Pharma US, Inc....
Read more about Astellas Oncology Announces Grand Prize Winner of Fifth Annual C³ Prize® Challenge
Oncology head Mark Reisenauer named Astellas US President; Masahide Goto named President at Astellas Institute for Regenerative Medicine NORTHBROOK, Ill. and BOSTON, Feb. 4, 2021 /PRNewswire/ --...
NORTHBROOK, Ill., Jan. 28, 2021 /PRNewswire/ -- For the seventh consecutive year, Astellas has achieved a perfect score on the Human Rights Campaign Foundation's (HRC) annual Corporate Equality Index
Sponsorship provides a year of access to MBC BioLabs' life-science incubators and in-house Astellas expertise SAN FRANCISCO, Dec. 14, 2020 /PRNewswire/ -- Astellas Venture Management (President:...
- AXONIS Therapeutics, Inc. and Tenza win a year of access to life-science incubator in Cambridge, MA and access to Astellas expertise to further their research - CAMBRIDGE, Mass., Oct. 8, 2020...
Follow U.S. news
